UNIFI 1.6 is Industry’s First Multi-User, Server-Based Technology for Management of Analytical LC, LC/MS, and LC/MS/MS Data

Waters Corporation (NYSE: WAT) is now shipping UNIFI^® Scientific Information System, release version 1.6, for the Waters^® Biopharmaceutical Platform Solution, Regulated Bioanalysis Platform Solution, Screening Platform Solution, Pesticide Screening Application Solution and Metabolite Identification Application Solution. UNIFI 1.6 features improved software performance, default and customizable workflows capabilities, and multi-user server-based connectivity. 

“With industry-leading core technology positions in separations, detection, chemistries, and informatics, Waters is uniquely positioned to develop systems that optimize technology performance for dedicated application areas,” said Dr. Rohit Khanna, Vice President of Informatics and Worldwide Marketing for the Waters Division. “With each release of UNIFI, we are working and collaborating with customers to guide development of future platform and application solutions. The expansion of UNIFI-based solutions is an evolutionary process that is proving successful for our customers.”

With version 1.6, UNIFI significantly expands its available laboratory footprint from a single workstation to support multi-user, server-based workgroups for the capture, storage, and management of analytical LC, LC/MS, and LC/MS/MS data across applications. Additionally with this release, UNIFI advances its ability to manage and store exponentially larger dataset files with improved robustness, performance, and processing speed.

“This is major step forward towards Waters’ vision for UNIFI as an enterprise-wide Scientific Information System,” continued Dr. Khanna. “UNIFI’s workgroup configuration is designed to support multiple scientists …within a common software environment. From acquisition to data interpretation to reporting, UNIFI comprehensively captures scientific workflow. UNIFI offers laboratory-dependent organizations improved abilities to unite the knowledge and improve productivity of their researchers.”

Biopharmaceutical Platform Solution with UNIFI™ is a targeted total solution for developers of biotherapeutics and biosimilars. The system solution consists of the ACQUITY UltraPerformance LC® (UPLC®) H-Class, the Xevo® G2-S QTof mass spectrometer, Waters’ application-tested bioseparation column chemistries, and analytical standards.

Regulated Bioanalysis Platform Solution with UNIFI is an LC/MS/MS system for drug metabolism and pharmacokinetic (DMPK) organizations and CROs that combines the latest in sample preparation, UPLC and chemistries, and tandem quadrupole mass spectrometry.

Screening Platform Solution with UNIFI is the first and only comprehensive screening solution to target, identify, quantify and review based on a streamlined analytical workflow that enables more accurate results across a variety of applications.  The holistically designed Platform Solution consists of the ACQUITY UPLC I-Class, the Xevo G2-S QTof mass spectrometer, Waters Analytical Standards & Reagents and Waters Chemistries.

Pesticide Screening Application Solution with UNIFI delivers the ease-of-use, sensitivity, stability, reproducibility, and throughput scientists need to successfully and profitably perform pesticide residue screening in a manner compliant with regulatory requirements today and in the future.

Metabolite Identification Application Solution with UNIFI is the world’s most comprehensive metabolite identification system assisting the DMPK scientist in identifying and characterizing metabolites in both discovery and development environments. Chemically intelligent yet flexible workflows are at the core of UNIFI’s design. The workflow approach integrates both quantitative and qualitative datasets and workflows into a single analysis.

About Waters Corporation

For over 50 years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY UPLC, UPLC, UltraPerformance LC, XSelect, Xevo, UNIFI, GlycoWorks, AutoBlend Plus, Stepwave, Q-Tof and CSH are trademarks of Waters Corporation.

more about Waters

more news from Waters